213411-84-8
213411-84-8
Chemical Structure
BM152054
- CAS No.: 213411-84-8
- Formula:C22H18N2O4S3
- Molecular Weight:470.58
IUPAC Name: 5-((4-(2-(5-methyl-2-(thiophen-2-yl)oxazol-4-yl)ethoxy)benzo[b]thiophen-7-yl)methyl)thiazolidine-2,4-dione
InChIKey: MZRQLASUMBMPRS-UHFFFAOYSA-N
SMILES: O=C(N1)SC(CC2=C3C(C=CS3)=C(OCCC4=C(C)OC(C5=CC=CS5)=N4)C=C2)C1=O
Biological Activity: BM152054 is a potent PPARgamma-activator. BM152054 can promote glucose utilization in peripheral tissues by enhancing insulin action[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BM152054 | BM152054 is a potent PPARgamma-activator. BM152054 can promote glucose utilization in peripheral tissues by enhancing insulin action. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Yoel Kloog, et al. Ras inhibitors for treating diseases or pathological conditions characterized insulin resistance. WO 2012104846 A1
- [2]. Fürnsinn C, et al. Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism. Br J Pharmacol. 1999;128(6):1141-1148. [Content Brief]
